In line with our results from integrated bulk and single-cell RNA analyses, treating CLL cells with Perhexiline to inhibit FAO revealed a downregulation of LPL and CNR1 gene expression compared to untreated controls (Fig. 5H-I). The gene discussed is LPL; the disease is B-cell chronic lymphocytic leukemia.